My colleagues and I just submitted this public comment to FDA opposing its proposal to allow sales of flavored e-cigarettes and other electronic nicotine delivery systems (ENDS) on the grounds that benefits to adults would outweigh harms to kids. It also presents evidence that two-way communication between ENDS and external agencies (that could include ENDSContinue reading “FDA should drop its draft guidance to allow some sales of flavored e-cigs because it ignores evidence that harm to youth outweighs theoretical benefits to adults”
Category Archives: FDA
I surprised Michael Smerconsih when he interviewed me about UK generational smoking ban
On April 23, 2026, Michael Smerconsih interviewed me about the UK Generational Smoking ban. I surprised him by arguing that generational smoking bans are bad public policy because they divert resources from more effective tobacco control policies that had faster public health benefits. I am also skeptical that they will be maintained in the longContinue reading “I surprised Michael Smerconsih when he interviewed me about UK generational smoking ban”
FDA adds 18 chemicals to list of harmful constituents in tobacco products, including propelyene glycol and vegetable glycerine
The FDA is required to maintain a list of “Harmful and Potentially Harmful Constituents” (HPHC) in tobacco products. The original list was released in 2012 and was mostly toxicants in cigarette and other tobacco smoke and smokeless tobacco. In particular, this list did not include important compounds in e-cigarettes and other “new” tobacco products. InContinue reading “FDA adds 18 chemicals to list of harmful constituents in tobacco products, including propelyene glycol and vegetable glycerine”
FDA releases 2025 NYTS data without any analysis; Altria and Rutgers (separately) provide summary results
In April 2025, the Trump Administration shuttered the CDC Office on Smoking and Health and stopped collecting data for the 2025 National Youth Tobacco Survey. Later, the Administration announced it was restoring the NYTS and transferring is administration to the FDA Center For Tobacco Products, which had been partnering with CDC since 2021. On MarchContinue reading “FDA releases 2025 NYTS data without any analysis; Altria and Rutgers (separately) provide summary results”
E-cigarettes are nearly as risky as cigarettes; dual use is worse: The evidence continues to pile up
Using e-cigarettes (vaping) has been promoted as a much safer alternative to smoking cigarettes. However, a new head-to-head comparison of actual disease in e-cigarette users compared to cigarette smokers published in Public Health Reports shows that this assertion is wrong. This new analysis of 124 studies on the association of e-cigarette use with disease outcomesContinue reading “E-cigarettes are nearly as risky as cigarettes; dual use is worse: The evidence continues to pile up”
FDA broke the law when it did not allow TPSAC to vote on whether to allow PMI to make modified risk claims for ZYN
The FDA held a meeting of its Tobacco Products Scientific Advisory Committee (TPSAC) on January 22, 2026 to discuss Swedish Match’s application to make the modified risk tobacco product (MRTP) claim for its ZYN flavored nicotine pouches “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer,Continue reading “FDA broke the law when it did not allow TPSAC to vote on whether to allow PMI to make modified risk claims for ZYN”
RFK Jr strongly endorses tobacco industry harm reduction argument for ecigs and nicotine pouches
In a video interview circulated by Danny Gillis owner of SevierVapor and Executive Director Tennessee Smoke Free Association, Health and Human Services Secretary Robert F. Kennedy, Jr strongly endorses e-cigarettes and nicotine pouches for “harm reduction.” He also cites industry arguments that nicotine helps people with Alzheimer’s disease and dimentia (at 50 seconds in theContinue reading “RFK Jr strongly endorses tobacco industry harm reduction argument for ecigs and nicotine pouches”
Plain language summary of meta-analysis of ecigs and disease available
Last year we published “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes” that showed that some disease risks of e-cigarettes are indistinguishable from cigarettes and for others they on only slightly lower. This paper continues to attract interest, so I prepared a one page plain language summary, together with some frequently asked questions.Continue reading “Plain language summary of meta-analysis of ecigs and disease available”
FDA Tobacco Products Scientific Advisory Committee should recommend against FDA allowing Philip Morris Products continuing to make misleading reduced risk claims about IQOS
FDA has scheduled a virtual meeting of its Tobacco Products Scientific Advisory Committee (TPSAC) meeting for October 7, 2025, to discuss the modified risk tobacco product (MRTP) renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products that is happening despite the government shutdown. (Participants can attend via a live webcast.)Continue reading “FDA Tobacco Products Scientific Advisory Committee should recommend against FDA allowing Philip Morris Products continuing to make misleading reduced risk claims about IQOS”
FDA’s product standard setting a maximum level of nicotine should be expanded to all tobacco products including e-cigs and nicotine pouches
My colleagues at UCSF and Stanford and I have submitted this public comment to the FDA on its prposed nicotine standard urging that the standard be extended to all tobacco products (PDF). The regulations.gov Comment Tracking Number: mfj-v5cz-15yf. The scope of FDA’s proposed tobacco product standard setting a maximum level of nicotine in tobacco productsContinue reading “FDA’s product standard setting a maximum level of nicotine should be expanded to all tobacco products including e-cigs and nicotine pouches”
Stanton Glantz blog 